DK1133497T3 - Krystalmodifikation B af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre - Google Patents

Krystalmodifikation B af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre

Info

Publication number
DK1133497T3
DK1133497T3 DK99959278T DK99959278T DK1133497T3 DK 1133497 T3 DK1133497 T3 DK 1133497T3 DK 99959278 T DK99959278 T DK 99959278T DK 99959278 T DK99959278 T DK 99959278T DK 1133497 T3 DK1133497 T3 DK 1133497T3
Authority
DK
Denmark
Prior art keywords
quinolinecarboxylic
nonan
diazabicyclo
cyan
cyclopropyl
Prior art date
Application number
DK99959278T
Other languages
English (en)
Inventor
Thomas Himmler
Werner Hallenbach
Hubert Rast
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1133497T3 publication Critical patent/DK1133497T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK99959278T 1998-11-25 1999-11-15 Krystalmodifikation B af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre DK1133497T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854355A DE19854355A1 (de) 1998-11-25 1998-11-25 Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PCT/EP1999/008776 WO2000031076A1 (de) 1998-11-25 1999-11-15 Kristallmodifikation b von 8-cyan- 1-cyclopropyl -7-(1s,6s-2, 8-diazabicyclo -[4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro- 4-oxo-3- chinolincarbonsaure

Publications (1)

Publication Number Publication Date
DK1133497T3 true DK1133497T3 (da) 2005-05-17

Family

ID=7888959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99959278T DK1133497T3 (da) 1998-11-25 1999-11-15 Krystalmodifikation B af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre

Country Status (29)

Country Link
US (1) US6664268B1 (da)
EP (1) EP1133497B1 (da)
JP (2) JP5127094B2 (da)
KR (1) KR100740950B1 (da)
CN (1) CN1150193C (da)
AR (1) AR028467A1 (da)
AT (1) ATE289606T1 (da)
AU (1) AU767890B2 (da)
BR (1) BRPI9915682B8 (da)
CA (1) CA2351707C (da)
CZ (1) CZ300012B6 (da)
DE (2) DE19854355A1 (da)
DK (1) DK1133497T3 (da)
ES (1) ES2237186T3 (da)
HK (1) HK1042705B (da)
HU (1) HU229071B1 (da)
IL (2) IL142695A0 (da)
NO (1) NO318065B1 (da)
NZ (1) NZ511862A (da)
PL (1) PL196078B1 (da)
PT (1) PT1133497E (da)
RU (1) RU2248355C2 (da)
SK (1) SK285554B6 (da)
TR (1) TR200101444T2 (da)
TW (1) TWI245767B (da)
UA (1) UA67873C2 (da)
UY (1) UY25818A (da)
WO (1) WO2000031076A1 (da)
ZA (1) ZA200103187B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006049520A1 (de) * 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
WO2018146194A1 (en) 2017-02-13 2018-08-16 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JP2832848B2 (ja) * 1989-10-21 1998-12-09 株式会社林原生物化学研究所 結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
BR9509688A (pt) * 1994-11-18 1997-09-30 Upjohn Co Composto e composição farmacêutica
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
DK0882049T3 (da) * 1996-02-23 2003-03-03 Bayer Ag Eventuelt substituerede 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer og deres derivater
DE19649681A1 (de) * 1996-11-29 1998-06-04 Basf Ag Verfahren zur Herstellung eines kristallinen Feststoffes aus Glycin-N,N-diessigsäure-Derivaten mit hinreichend geringer Hygroskopizität
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure

Also Published As

Publication number Publication date
TWI245767B (en) 2005-12-21
ZA200103187B (en) 2002-06-26
UY25818A (es) 2016-06-30
BR9915682A (pt) 2001-08-14
PT1133497E (pt) 2005-07-29
WO2000031076A1 (de) 2000-06-02
SK6832001A3 (en) 2001-12-03
CZ300012B6 (cs) 2009-01-14
EP1133497A1 (de) 2001-09-19
NO20012461L (no) 2001-05-18
TR200101444T2 (tr) 2002-01-21
CZ20011857A3 (cs) 2001-09-12
CA2351707C (en) 2011-02-01
IL142695A (en) 2006-04-10
ATE289606T1 (de) 2005-03-15
RU2248355C2 (ru) 2005-03-20
EP1133497B1 (de) 2005-02-23
US6664268B1 (en) 2003-12-16
KR100740950B1 (ko) 2007-07-19
NO318065B1 (no) 2005-01-31
UA67873C2 (uk) 2004-07-15
HK1042705B (zh) 2005-03-11
PL196078B1 (pl) 2007-12-31
DE59911666D1 (de) 2005-03-31
JP2002530407A (ja) 2002-09-17
JP2012236841A (ja) 2012-12-06
KR20010080927A (ko) 2001-08-25
HK1042705A1 (en) 2002-08-23
IL142695A0 (en) 2002-03-10
HU229071B1 (en) 2013-07-29
CN1150193C (zh) 2004-05-19
SK285554B6 (sk) 2007-03-01
JP5127094B2 (ja) 2013-01-23
AU1651700A (en) 2000-06-13
NZ511862A (en) 2003-08-29
BRPI9915682B1 (pt) 2017-02-21
HUP0104713A3 (en) 2002-12-28
DE19854355A1 (de) 2000-05-31
AR028467A1 (es) 2003-05-14
CN1328556A (zh) 2001-12-26
PL347785A1 (en) 2002-04-22
HUP0104713A2 (hu) 2002-04-29
NO20012461D0 (no) 2001-05-18
BRPI9915682B8 (pt) 2021-05-25
CA2351707A1 (en) 2000-06-02
ES2237186T3 (es) 2005-07-16
AU767890B2 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
CU23015A3 (es) Formas cristalinas de eto2c-ch2-(r)cgl-aze-pab-oh.
ATE256684T1 (de) Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
DK1105390T3 (da) Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme
DK1133497T3 (da) Krystalmodifikation B af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
DE60003893D1 (de) 2-aminopyridine mit kondensierten ringsubstituenten
DK1133496T3 (da) Krystalmodifikation A af 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK1133495T3 (da) Semihydrochlorid af 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyre
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
IS5654A (is) Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim
DK1088817T3 (da) Fremgangsmåde til fremstilling af 3-acyl-indoler
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
NO20014059D0 (no) Krystallmodifikasjon D av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo-/4.3.0/-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyre
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1159296T3 (da) Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly)
AU5818300A (en) N-substituted perhydro diazine
DK1175420T3 (da) Fremgangsmåde til fremstilling af N6-substituerede deaza-adenosinderivater
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler
FI991294A (fi) Nikkelirikasteen valmistusmenetelmä
DK1296955T3 (da) Fremgangsmåde til fremstilling af 1,8-naphthalimid